Literature DB >> 12615611

Variability in the incidence of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infection among young injecting drug users in New York City.

Don C Des Jarlais1, Theresa Diaz, Theresa Perlis, David Vlahov, Carey Maslow, Mary Latka, Russell Rockwell, Vincent Edwards, Samuel R Friedman, Edgar Monterroso, Ian Williams, Richard S Garfein.   

Abstract

Cohort studies of young (aged 18-30 years) injecting drug users recruited in 1997-1999 in the Harlem and Lower East Side areas of New York City, New York, were used to assess the incidence of human immunodeficiency virus (HIV), hepatitis B virus (HBV), and hepatitis C virus (HCV). The authors found that HIV incidence was low at both sites: 0.8/100 person-years at the Harlem site and 0/100 person-years at the Lower East Side site. In contrast, HBV incidence was moderate (12.2/100 person-years) at the Harlem site and high (30.7/100 person-years) at the Lower East Side site. Similarly, HCV incidence was moderate (9.3/100 person-years) at the Harlem site and high (34.0/100 person-years) at the Lower East Side site. Results show that high rates of HBV and HCV transmission do not imply high rates of HIV transmission, even within an area of high HIV seroprevalence.

Entities:  

Mesh:

Year:  2003        PMID: 12615611     DOI: 10.1093/aje/kwf222

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  56 in total

Review 1.  Meta-analysis of hepatitis C seroconversion in relation to shared syringes and drug preparation equipment.

Authors:  Enrique R Pouget; Holly Hagan; Don C Des Jarlais
Journal:  Addiction       Date:  2012-04-17       Impact factor: 6.526

Review 2.  Updating the infection risk reduction hierarchy: preventing transition into injection.

Authors:  David Vlahov; Crystal M Fuller; Danielle C Ompad; Sandro Galea; Don C Des Jarlais
Journal:  J Urban Health       Date:  2004-03       Impact factor: 3.671

3.  HIV incidence among injection drug users in New York City, 1990 to 2002: use of serologic test algorithm to assess expansion of HIV prevention services.

Authors:  Don C Des Jarlais; Theresa Perlis; Kamyar Arasteh; Lucia V Torian; Sara Beatrice; Judith Milliken; Donna Mildvan; Stanley Yancovitz; Samuel R Friedman
Journal:  Am J Public Health       Date:  2005-06-28       Impact factor: 9.308

4.  Assessment of HIV testing of urban injection drug users: implications for expansion of HIV testing and prevention efforts.

Authors:  Robert Heimer; Lauretta E Grau; Erin Curtin; Kaveh Khoshnood; Merrill Singer
Journal:  Am J Public Health       Date:  2006-11-30       Impact factor: 9.308

5.  Effectiveness of respondent-driven sampling for recruiting drug users in New York City: findings from a pilot study.

Authors:  Abu S Abdul-Quader; Douglas D Heckathorn; Courtney McKnight; Heidi Bramson; Chris Nemeth; Keith Sabin; Kathleen Gallagher; Don C Des Jarlais
Journal:  J Urban Health       Date:  2006-05       Impact factor: 3.671

6.  A syringe exchange programme in prison as prevention strategy against HIV infection and hepatitis B and C in Berlin, Germany.

Authors:  K Stark; U Herrmann; S Ehrhardt; U Bienzle
Journal:  Epidemiol Infect       Date:  2005-12-22       Impact factor: 2.451

7.  Injecting alone among young adult IDUs in five US cities: evidence of low rates of injection risk behavior.

Authors:  Holly Hagan; Jennifer V Campbell; Hanne Thiede; Steffanie A Strathdee; Lawrence Ouellet; Mary Latka; Sharon Hudson; Richard S Garfein
Journal:  Drug Alcohol Depend       Date:  2007-03-23       Impact factor: 4.492

8.  Integrating viral hepatitis prevention into public health programs serving people at high risk for infection: good public health.

Authors:  Joanna Buffington; T Stephen Jones
Journal:  Public Health Rep       Date:  2007       Impact factor: 2.792

9.  The relationship of sexual dyad and personal network characteristics and individual attributes to unprotected sex among young injecting drug users.

Authors:  V Anna Gyarmathy; Alan Neaigus
Journal:  AIDS Behav       Date:  2007-08-10

10.  Healthy places: exploring the evidence.

Authors:  Howard Frumkin
Journal:  Am J Public Health       Date:  2003-09       Impact factor: 9.308

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.